tirzepatide fda news says shortage of GLP-1 drug is over Huge news: FDA has approved

These drugs were originally developed for diabetes therapy, but found uses in their ability to treat obesity and help people lose weight

Quick Answer: GLP-1 receptor agonists do not directly cause frequent urination as a pharmacological effect, though some patients may experience urinary changes due to indirect factors like weight loss, improved glycemic control, or hydration changes

Is Vyvanse Addictive

This information may help provide context for provider conversations about which formulation and dose strategy could align with an individual's genetic profile, though genetic variants do not predict exact medication response